These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 27169770)

  • 1. Surgeons' Perspectives of Contralateral Prophylactic Mastectomy.
    Bellavance E; Peppercorn J; Kronsberg S; Greenup R; Keune J; Lynch J; Collyar D; Magder L; Tilburt J; Hlubocky F; Yao K
    Ann Surg Oncol; 2016 Sep; 23(9):2779-87. PubMed ID: 27169770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plastic and Reconstructive Surgeons' Knowledge and Comfort of Contralateral Prophylactic Mastectomy: A Survey of the American Society of Plastic Surgeons.
    Lopez CD; Bluebond-Langner R; Houssock CA; Slezak SS; Bellavance E
    Front Oncol; 2018; 8():647. PubMed ID: 30687634
    [No Abstract]   [Full Text] [Related]  

  • 3. Practitioner Opinion on Contralateral Prophylactic Mastectomy: How Do We Steer a Patient-Driven Discussion?
    Schellenberg AE; Stypulkowski A; Cordeiro E; Holloway CMB; Eisen A; Scheer AS
    Ann Surg Oncol; 2019 Oct; 26(11):3489-3494. PubMed ID: 31187367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast surgeons' perceptions and attitudes towards contralateral prophylactic mastectomy.
    Musiello T; Bornhammar E; Saunders C
    ANZ J Surg; 2013 Jul; 83(7-8):527-32. PubMed ID: 23043449
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral Prophylactic Mastectomy (CPM) Consensus Statement from the American Society of Breast Surgeons: Data on CPM Outcomes and Risks.
    Boughey JC; Attai DJ; Chen SL; Cody HS; Dietz JR; Feldman SM; Greenberg CC; Kass RB; Landercasper J; Lemaine V; MacNeill F; Song DH; Staley AC; Wilke LG; Willey SC; Yao KA; Margenthaler JA
    Ann Surg Oncol; 2016 Oct; 23(10):3100-5. PubMed ID: 27469117
    [No Abstract]   [Full Text] [Related]  

  • 6. Exploring Surgeon Variability in Recommendations for Contralateral Prophylactic Mastectomy: What Matters Most?
    Taylor MA; Allen CM; Presson AP; Millar MM; Zurbuchen R; Matsen CB
    Ann Surg Oncol; 2019 Oct; 26(10):3224-3231. PubMed ID: 31342374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral Prophylactic Mastectomy for Women with T4 Locally Advanced Breast Cancer.
    Murphy BL; Hoskin TL; Boughey JC; Degnim AC; Glazebrook KN; Hieken TJ
    Ann Surg Oncol; 2016 Oct; 23(10):3365-70. PubMed ID: 27364506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States.
    Yao K; Bleicher R; Moran M; Chang C; Dietz J; Stearns V; Connolly J; Sarantou T; Kurtzman S;
    Cancer Med; 2020 May; 9(9):3088-3096. PubMed ID: 32159280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychosocial factors associated with the uptake of contralateral prophylactic mastectomy among BRCA1/2 mutation noncarriers with newly diagnosed breast cancer.
    Hamilton JG; Genoff MC; Salerno M; Amoroso K; Boyar SR; Sheehan M; Fleischut MH; Siegel B; Arnold AG; Salo-Mullen EE; Hay JL; Offit K; Robson ME
    Breast Cancer Res Treat; 2017 Apr; 162(2):297-306. PubMed ID: 28150129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women's preferences for contralateral prophylactic mastectomy following unilateral breast cancer: What risk-reduction makes it worthwhile?
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Costa D; Musiello T; Marven M; Butow P
    Breast; 2017 Feb; 31():233-240. PubMed ID: 27969575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgeon Influence on Variation in Receipt of Contralateral Prophylactic Mastectomy for Women With Breast Cancer.
    Katz SJ; Hawley ST; Hamilton AS; Ward KC; Morrow M; Jagsi R; Hofer TP
    JAMA Surg; 2018 Jan; 153(1):29-36. PubMed ID: 28903158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Women's preferences for contralateral prophylactic mastectomy: An investigation using protection motivation theory.
    Tesson S; Richards I; Porter D; Phillips KA; Rankin N; Musiello T; Marven M; Butow P
    Patient Educ Couns; 2016 May; 99(5):814-22. PubMed ID: 27529090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does a brief surgeon training in negotiation theory principles decrease rates of contralateral prophylactic mastectomy?
    Mamtani A; Sjoberg DD; Vincent A; Ehdaie B; Malhotra D; Vickers A; Morrow M
    Breast Cancer Res Treat; 2023 May; 199(1):119-126. PubMed ID: 36881270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the Effect of Lifetime Contralateral Breast Cancer Risk on the Selection of Contralateral Prophylactic Mastectomy for Unilateral Breast Cancer.
    Hegde JV; Wang X; Attai DJ; DiNome ML; Kusske A; Hoyt AC; Hurvitz SA; Weidhaas JB; Steinberg ML; McCloskey SA
    Clin Breast Cancer; 2018 Apr; 18(2):e205-e218. PubMed ID: 29050918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contralateral Prophylactic Mastectomy Decisions in a Population-Based Sample of Patients With Early-Stage Breast Cancer.
    Jagsi R; Hawley ST; Griffith KA; Janz NK; Kurian AW; Ward KC; Hamilton AS; Morrow M; Katz SJ
    JAMA Surg; 2017 Mar; 152(3):274-282. PubMed ID: 28002555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Breast Cancer Knowledge and Decisions Made for Contralateral Prophylactic Mastectomy: A Survey of Surgeons and Women in the General Population.
    Hooper RC; Hsu J; Duncan A; Bensenhaver JM; Newman LA; Kidwell KM; Chung KC; Momoh AO
    Plast Reconstr Surg; 2019 May; 143(5):936e-945e. PubMed ID: 31033815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Striving to Do No Harm and Yet Respect Patient Autonomy: Plastic Surgeons' Perspectives of the Consultation for Breast Reconstruction with Women Who Have Early-Stage Breast Cancer.
    Schmocker S; Gotlib Conn L; Kennedy ED; Zhong T; Wright FC
    Ann Surg Oncol; 2019 Oct; 26(10):3380-3388. PubMed ID: 31342367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical management factors contribute to the decision for contralateral prophylactic mastectomy.
    King TA; Sakr R; Patil S; Gurevich I; Stempel M; Sampson M; Morrow M
    J Clin Oncol; 2011 Jun; 29(16):2158-64. PubMed ID: 21464413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contralateral prophylactic mastectomy for unilateral breast cancer in women at average risk: Systematic review of patient reported outcomes.
    Srethbhakdi A; Brennan ME; Hamid G; Flitcroft K
    Psychooncology; 2020 Jun; 29(6):960-973. PubMed ID: 32201988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact that Timing of Genetic Mutation Diagnosis has on Surgical Decision Making and Outcome for BRCA1/BRCA2 Mutation Carriers with Breast Cancer.
    Chiba A; Hoskin TL; Hallberg EJ; Cogswell JA; Heins CN; Couch FJ; Boughey JC
    Ann Surg Oncol; 2016 Oct; 23(10):3232-8. PubMed ID: 27338744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.